WFDC2 and ovarian carcinoma: Therefore, combining these biomarkers with other established diagnostic markers—such as Human Epididymis Protein 4 (HE4) or exosomal miRNAs—may enhance diagnostic accuracy and contribute to earlier detection of ovarian cancer [68].